On Thursday, the trial judge had bad news for Javice: she'll have to share the defense table with a codefendant planning to attack her.
Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.